The dropless future: SLT as a first-line treatment for glaucoma ByKristin O. Chapman, MDApril 28th 2020
Glaucoma 360: New developments in pharma (Ellie Chabi, MD; Santen, Inc)ByAlex Delaney-Gesing April 14th 2020
Glaucoma 360: Glaucoma devices update with Victor Chan, MB, MS (Santen Inc)ByAlex Delaney-Gesing April 13th 2020
Sustained-release implant offers long-term IOP control, preserved visual function ByLynda ChartersMarch 20th 2020
John Berdahl, MD: I have an idea ... now what?ByAlex Delaney-Gesing ,Sheryl StevensonFebruary 18th 2020